SCHEMBL7305142

SCHEMBL7305142

CC[C@H](C)[C@H](NC(=O)N(C)Cc1ccc2ccccc2n1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
ADAMTS4 O75173 1/20 0.43
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 1/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
PRNP P04156 1/20 0.41
MAPK10 P53779 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
PYGL P06737 1/20 0.40
CA2 P00918 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
AGTR2 P50052 1/20 0.40
ELANE P08246 1/20 0.39
PDK1 Q15118 1/20 0.39
FPR2 P25090 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27372584 1.00 CYP1A2 (0.44) CYP1A2ADAMTS4CYP2C9CYP2C19HDAC1
SCHEMBL7337376 0.91 CYP1A2 (0.48) CYP1A2ADAMTS4HDAC1HDAC2KDM4E
SCHEMBL7337373 0.91 CYP1A2 (0.48) CYP1A2ADAMTS4HDAC1HDAC2KDM4E
SCHEMBL7300357 0.85 HDAC1 (0.46) CYP1A2HDAC1HDAC2KDM4EALDH1A1
SCHEMBL27375082 0.85 HDAC1 (0.46) CYP1A2HDAC1HDAC2KDM4EALDH1A1
SCHEMBL7388688 0.85 CYP1A2 (0.43) CYP1A2ADAMTS4HDAC1HDAC2KDM4E
SCHEMBL7298672 0.82 CYP1A2 (0.43) CYP1A2CYP2C9HDAC1HDAC2KDM4E
SCHEMBL7299517 0.81 CYP3A4 (0.45) CYP1A2CYP2C9CYP2C19CA2ELANE
SCHEMBL7393135 0.81 CA2 (0.60) CYP1A2ADAMTS4CYP2C9CYP2C19ALDH1A1
SCHEMBL7302427 0.81 CA2 (0.60) CYP1A2ADAMTS4CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0652009-A1 Identification and use of protease inhibitors ELI LILLY AND COMPANY (US) 1995-05-10 EP disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed